Michael Sherman

About Michael Sherman

Dr. Michael Sherman is Principal at Sherman Healthcare Solutions, LLC, a firm providing consulting services, fractional executive-level support, and independent board service to the healthcare industry. He serves as an advisor to multiple investment funds, focusing on healthcare services, life sciences, diagnostics, healthcare technology, and related areas, particularly addressing issues relating to market access, pricing and reimbursement, and he holds a faculty appointment in the Department of Population Medicine at Harvard Medical School. Prior to May 2025, he spent two years as a full-time venture partner at RA Capital Management, which he still advises.Prior to joining RA, Dr. Sherman served as executive vice president and chief medical officer at Point32Health, formed by the merger of Harvard Pilgrim Health Care and Tufts Health Plan. Prior to the merger, he served as chief medical officer of Harvard Pilgrim Health Care, nationally recognized for both innovation and quality. He has been widely recognized as a pioneer in bringing advances in transformational therapeutics, precision medicine, and digital therapeutics to Point32Health’s members by launching structured pilots that balance access and affordability while also generating real world evidence that received national attention.In 2018, he received Xconomy’s “Contrarian Award” for his contributions, including having developed and executed the nation’s first value-based payment model for a gene therapy, and his work is also featured in a Harvard Business School case study published in 2021. Dr. Sherman has also led the nation in expanding access to precision medicine, such as whole genome screening, and his organization became the first health plan to cover the GRAIL Galleri Multi-Cancer Early Detection Blood Test for a subset of its commercial members in 2022. Dr. Sherman currently serves as board member of Real Endpoints and until recently, served as a director of Vesta Health and board observer and advisor to Commons Clinic. He is also currently a member of the Harvard Business School Healthcare Initiative Advisory Board. For over a decade, he served as Chair of the Board of Managers of the Harvard Pilgrim Health Care Institute, which encompasses the Department of Population Medicine at Harvard Medical School. Dr. Sherman has also served on the boards of the Personalized Medicine Coalition, at which he sat on the Executive Committee, and NEHI (Network for Excellence in Health Innovation).

Experience

1. Advisor

   RA Capital Management

   May 2025 — Present · Boston, MA, US

Education

• Harvard Business School

  MBA, General Management

  1996 — 1997

• Yale School of Medicine

  MD, Medicine

  1982 — 1986

• Poly Prep Country Day School

  High School Diploma

  1974 — 1978

• University of Pennsylvania

  BA, MS, Biomedical Anthropology

  1978 — 1982

Skills

• Hospitals
• Public Health
• Physicians
• Hipaa
• Medicine
• Quality Improvement
• Oncology
• Informatics
• Cross-Functional Team Leadership
• Healthcare Consulting
• Utilization Management
• Strategy
• Leadership
• Medicaid
• Innovation
• Healthcare Management
• Healthcare
• Business Development
• Healthcare Information Technology
• Strategic Partnerships
• Partnerships
• Strategic Planning
• Clinical Research
• Ehr
• Health Insurance
• Medicare
• Managed Care
• Health Policy
• Emr
• Insurance
• Healthcare Industry
• Outcome Driven Innovation
• Disease Management
• Program Management
• Process Improvement